Hyung Suh, M.D., PhD, is a hematologist-oncologist who specializes in the care of people with blood diseases (such as leukemia, myelodysplastic syndrome, myeloproliferative disorders, lymphoma, aplastic anemia, sickle cell disease, and multiple myeloma) by using stem cell transplantation, cellular therapy, and immunotherapy. He is also an experienced biomedical scientist with expertise in hematology-oncology research and the translation of research findings from the laboratory to the patients they may help.
A native of South Korea, Dr. Suh graduated from Yonsei University College of Medicine in Seoul, where he earned his MD degree in 1992 and his PhD in Medical Science in 2004. He has participated in research programs exploring leukemia, anemia, myeloproliferative disease, bone marrow failure, and bone marrow transplantation in Korea as well as at the National Cancer Institute in Frederick, Maryland, publishing numerous scientific papers in peer-reviewed scientific journals.
His career continued at UCLA, where he was a clinical assistant professor and director of the stem cell laboratory before coming to John Theurer Cancer Center. He is active in clinical trials for evaluating immunotherapy and cellular therapy for various hematologic diseases and malignancies. Dr. Suh is a member of the American Society of Hematology and the American Society for Transplantation and Cellular Therapy.